Immunity Pharma Ltd.
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)โข Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Immunity Pharma Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03755167
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center/Neuromuscular / EMG service and ALS / Motor Neuron Disease Clinic, Jerusalem, Israel
๐ฎ๐ฑHadassah Medical Center -Motor Neuron Disease Clinic, Jerusalem, Israel
A Study of IPL344 in the Treatment of ALS Patients
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Immunity Pharma Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03652805
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center -Motor Neuron Disease Clinic, Jerusalem, Israel
News
No news found